Spatial Companies: Up & Comers 2026
Here are 10 “Up & Comers” spatial biology companies that are not large enough to be ranked as public or private companies, but warrant mention based on recent financings, collaborations, new products, attention in peer-reviewed publications, and other developments.
Top 10 Contract Development and Manufacturing Organizations 2026
Alex Philippidis analyzes the top CDMOs this year, noting a bright future as biopharma is expected to increase their reliance on CDMOs in coming years despite rising costs for their services. Which companies made the top 10 list? Check out the list to find out.
10 CDMO Up & Comers 2026
The companies listed here, in the “CDMO Up & Comers List” are noted for making headlines with facility openings, major contracts, and other significant actions, though not yet large enough to crack the A-List Top 10 CDMOs.
ISSUE NO. 10, OCTOBER 2026
GEN Magazine
GEN Digital Edition
Access the latest issue of GEN and browse the archive of back issues when you subscribe to our digital edition.
The State of AI in Drug Discovery
GEN’s virtual summit returns on November 4 to examine how AI is reshaping R&D timelines and real-world patient translation. From big pharma to AI-natives, this year’s program features the leaders of many of today’s outstanding companies and organizations powering the AI revolution!
Aliza Apple, PhD
Vice President
Catalyze360 AI/ML, Eli Lilly
Sam Rodriques, PhD
Co-Founder, Director, and CEO
Edison Scientific and FutureHouse
Peyton Greenside, PhD
Co-Founder and CEO
BigHat Biosciences
Marc Tessier-Lavigne, PhD
Co-Founder, Chairman, and CEO
Xaira Therapeutics
Lock Down the Critical Factors in Oligo and Oligo-Conjugate Characterization with Stunner and Honeybun
Using AI Agents and Bio-Foundation Models to Automate Vector Design for Cell Line Development
How Preclinical Manufacturing Can De-Risk the Path to GMP-Ready Viral Vector Programs
Bridging the Translational Gap in Pancreatic Cancer Through Biology-First Modeling
Podcast
Touching Base
Touching Base is the dynamic podcast series from the editors of GEN. Each episode features a rotating case of senior editors—including John Sterling, Kevin Davies, Julianna LeMieux, Alex Phillippidis, Uduak Thomas, Corinna Singleman, and Fay Lin—who delve into emerging stories, exchange ideas, and debate the latest trends in biotech. Additionally, they talk to some of the leading voices in the industry about what’s now and next. Start listening today!
Stay up to date with the lasted episodes of Touching Base by subscribing to the GEN Podcast Newsletter
